Gyre Therapeutics is trading 10.05% higher at $5.01 in pre-market on November 2, 2026, with no company-specific announcement or clear catalyst identified.
- It closed at $4.55 on October 30.
- Its investor-relations page lists no newer release than September 3; available reporting identified no publicly disclosed explanation for the October 30 decline.
- The broader market is firmer, but that does not establish the cause of the pre-market move.